|
|
 |
|
HIV vaccines: where next? Nature Disappointing results in recent clinical trials of HIV vaccines are prompting a rethink. The accepted wisdom, that the important aim is to boost cellular immunity, may be jettisoned in favor of a search for better ways of stimulating antibody production. News feature article by Erica Check, Nature magazine’s Washington biomedical correspondent.
—Posted: July 1, 2003
More news headlines: This week | Last week | Search archive
|
|
|
